PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s stock price was down 3.4% on Friday . The company traded as low as ...

On November 21, Pre-Trial Chamber (PTC) of the International Criminal Court (ICC) formally issued arrest warrants for Israeli ...

Investing in high dividend-yield stocks has several benefits, particularly for income-focused investors. But there are some ...

PTC Therapeutics faces significant risks with its key revenue sources, Translarna and Emflaza. Find out why I am sticking ...

PTC Therapeutics has sold its rare pediatric disease priority review voucher (PRV) for $150 million, following FDA approval ...

PTC Therapeutics (PTCT) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150M upon the closing of the transaction. PTC was granted the ...

Retailers like Dunelm offer plenty of cost-effective heating solutions. Despite its compact size, the £18 Plug in PTC Heater ...

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price rose 4.8% on Tuesday after Robert W. Baird raised their price target on the stock from $48.00 to $52.00. Robert W. Baird currently ...

Report with the AI impact on market trends - The global predictive maintenance (PDM) market size is estimated to grow by USD ...

Administration for these structures requires compliance, which now includes the U.S. Corporate Transparency Act (the CTA).

Kronos is cutting 83% of its workforce, while Idorsia is considering eliminating as many as 270 jobs. Elsewhere, PTC ...

The announcement means the company will be pulling the plug on the CardinALS trial after its amyotrophic lateral sclerosis ...